Le Lézard
Classified in: Health, Business
Subjects: NPT, CSR, SCZ

Edward Jones Tops $6 million in Alzheimer's Association Fundraising Efforts


ST. LOUIS, Feb. 21, 2019 /PRNewswire/ -- Financial services firm Edward Jones, the first national presenting sponsor for the Alzheimer's Association annual Walk to End Alzheimer's®, raised  $3.3 million in 2018 through its 3,578 teams across the country. The firm's total contributions in support of the alliance last year topped $6 million, surpassing its 2017 contributions of $4.8 million

Edward Jones. (PRNewsFoto/Edward Jones) (PRNewsfoto/Edward Jones)

The Walk to End Alzheimer's® is the world's largest event to raise awareness and funds for Alzheimer's care, support and research. ­

"We strive to make a positive difference for our clients and our communities, and this is one way we can make a substantial impact. Too many of us have witnessed the devastation that this disease causes for those with the diagnosis, their friends, families and other caregivers," said Jeff Panchot, the principal leading the Edward Jones Older Adult Council. "Now in our third year of the strategic alliance with the Alzheimer's Association, our associates continue to raise the bar on giving back."

The strategic alliance, which began in 2016, has several facets. Edward Jones has worked with the Alzheimer's Association to create the Edward Jones Alzheimer's Research Fund, a targeted effort to accelerate research on treatment methods, prevention and, ultimately, a cure. The Alzheimer's Association also provides educational programs for Edward Jones associates so they can share resources with clients.

"As the Alzheimer's Association strives to engage more volunteers in meaningful roles, Edward Jones associates have stepped up as leaders in the fight by joining Walk to End Alzheimer's planning committees, chapter boards and as volunteer advocates to help advance our efforts for increased Alzheimer's research funding at the federal level," said Donna McCullough, Alzheimer's Association Chief Development Officer.  

Alzheimer's disease is the nation's sixth-leading cause of death and the only disease among the top 10 causes that cannot be prevented, cured or even slowed, according to the Alzheimer's Association. In the United States alone, more than 5 million people are living with the terminal brain disease, and this number is set to skyrocket to nearly 14 million by 2050 unless more effective treatments are found.

About Edward Jones
Edward Jones, a Fortune 500 company headquartered in St. Louis, provides financial services in the U.S. and through our affiliate in Canada. Every aspect of the firm's business, from the investments offered to the location of its branch offices, caters to individual investors. The firm's 17,000-plus financial advisors serve more than 7 million clients and care for more than $1 trillion in assets. Visit edwardjones.com or the recruiting website at careers.edwardjones.com. Member SIPC.

About the Alzheimer's Association
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. It is the largest nonprofit funder of Alzheimer's research. The Association's mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Its vision is a world without Alzheimer's. Visit www.alz.org or call 800-272-3900.

SOURCE Edward Jones


These press releases may also interest you

at 14:53
Erie Insurance (ERIE) has received the 2024 Best Employers: Excellence in Health & Well-being award from Business Group on Health. The annual corporate awards program recognizes companies across diverse sectors for advancing employee well-being...

at 14:41
Cartessa Aesthetics, a premier North American aesthetic medical device company, launches PHYSIQ 360, a groundbreaking technology that elevates non-invasive body contouring. PHYSIQ 360 is the next generation of the award-winning PHYSIQ body technology...

at 14:37
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of...

at 14:34
Arthritis is a crippling disease, affecting approximately one in four adults. It wreaks havoc on our joints by breaking down cartilage, the cushioning between bones. Once that cartilage deteriorates, there's no way to replace it. However, all this...

at 14:30
The American College of Lifestyle Medicine (ACLM), an 11,000-member society of medical professionals united to reverse chronic disease, and the National Medical Association (NMA), the largest and oldest national organization representing the...

at 14:29
Two Elder Care Alliance communities are recognized...



News published on and distributed by: